News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New type of diabetes drug funded

New type of diabetes drug funded

People with Type 2 diabetes are to have a new type of medicine to help manage their condition, following a decision by government drug-funding agency PHARMAC.

Pioglitazone (Actos) is to be fully funded for people with Type 2 diabetes, both as a therapy on its own or for use in combination with drugs known as sulphonylureas (such as glibenclamide).

PHARMAC Medical Director Dr Peter Moodie says obesity and Type 2 diabetes are significant and growing health issues for New Zealand, particularly affecting Maori and Pacific communities.

“The listing of pioglitazone will be a useful addition to currently available therapies for Type 2 diabetes,” Dr Peter Moodie says.

“Diabetes is a disease that can be very destructive to people and their families, so it is pleasing to be able to make this treatment available to New Zealanders.”

PHARMAC estimates that about 1000 people will initially be able to access fully subsidised pioglitazone in the first year, but that this figure will rise to about 3000.

Dr Peter Moodie says giving even more people access to pioglitazone will be one of PHARMAC’s priorities.

The treatment will be listed on the Pharmaceutical Schedule from 1 September 2004, and is the ninth new medicine added to the Schedule this year. The growing list of new investments also includes:

pegylated interferon in combination with ribavirin (for hepatitis C) venlafaxine (for severe depression) etanercept (for childhood arthritis) naltrexone (for alcohol addiction) lopinavir with ritonavir (for HIV/AIDS) ezetemibe (for raised cholesterol)

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
K Emma Ng's Old Asian, New Asian

This book, written by a young second-generation Chinese New Zealander, gives many examples of the racism that Asian New Zealanders experience. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION